AlphaCore Capital LLC Has $1.89 Million Holdings in McKesson Corporation $MCK

AlphaCore Capital LLC grew its position in McKesson Corporation (NYSE:MCK) by 36.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,438 shares of the company’s stock after purchasing an additional 652 shares during the quarter. AlphaCore Capital LLC’s holdings in McKesson were worth $1,885,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the company. Norges Bank acquired a new position in McKesson in the 2nd quarter valued at $1,346,661,000. Alliancebernstein L.P. lifted its holdings in shares of McKesson by 150.4% during the second quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock worth $1,661,956,000 after buying an additional 1,362,386 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of McKesson by 56.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock valued at $906,109,000 after acquiring an additional 446,060 shares during the period. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its stake in shares of McKesson by 45.6% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company’s stock valued at $610,977,000 after acquiring an additional 261,296 shares in the last quarter. Finally, Acadian Asset Management LLC grew its stake in shares of McKesson by 68.0% in the second quarter. Acadian Asset Management LLC now owns 636,596 shares of the company’s stock valued at $466,441,000 after acquiring an additional 257,670 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on MCK. TD Cowen boosted their price objective on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Robert W. Baird set a $968.00 price target on McKesson in a research report on Wednesday, January 14th. Mizuho raised their price objective on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Finally, Barclays lifted their price objective on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. Thirteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and a consensus target price of $943.50.

McKesson Stock Performance

NYSE MCK opened at $973.59 on Friday. The firm’s fifty day moving average price is $865.48 and its two-hundred day moving average price is $803.36. The stock has a market cap of $119.26 billion, a PE ratio of 28.00, a PEG ratio of 1.55 and a beta of 0.40. McKesson Corporation has a fifty-two week low of $619.48 and a fifty-two week high of $977.27.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.McKesson’s revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the company earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts predict that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson’s dividend payout ratio is currently 9.43%.

Insider Transactions at McKesson

In other McKesson news, Director Maria Martinez sold 349 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the transaction, the director directly owned 301 shares in the company, valued at approximately $282,900.87. This represents a 53.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 1,143 shares of company stock worth $1,046,070. 0.08% of the stock is owned by corporate insiders.

More McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Quarterly results showed revenue and operating profit ahead of expectations and management set FY‑2026 EPS guidance (38.80–39.20), reinforcing upward revisions to earnings expectations and investor confidence. A Look At McKesson (MCK) Valuation After Strong Earnings And Growing Analyst Optimism
• Positive Sentiment: Barclays raised its price target to $1,050 (from $960) and kept an Overweight rating, signaling continued analyst support that can attract additional fund buying. Barclays Boosts McKesson (MCK) Price Target, Says Shares Likely to Stay in Favor
• Positive Sentiment: Large institutional inflows have been a key technical driver this year; “big money” accumulation is cited as a reason for the stock’s strong multi‑month run and elevated relative performance. See How Institutional Inflows Make McKesson Fly
• Positive Sentiment: Shares reached an all‑time high, reinforcing momentum and likely triggering additional momentum/quant buying and headline attention. McKesson stock hits all-time high at 972.06 USD
• Neutral Sentiment: Coverage consensus is constructive (e.g., a “Moderate Buy” consensus from brokerages), but valuation metrics (P/E ~28, strong YTD gains) are noted — suggesting upside is supported but the stock could be sensitive to any guidance hiccups or macro shocks. McKesson Corporation (NYSE:MCK) Receives Consensus Rating of “Moderate Buy” from Brokerages

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.